KR20140020470A - Method for producing fermented herb extract with high gaba content using lactobacillus helveticus rmk85 - Google Patents
Method for producing fermented herb extract with high gaba content using lactobacillus helveticus rmk85 Download PDFInfo
- Publication number
- KR20140020470A KR20140020470A KR1020120086900A KR20120086900A KR20140020470A KR 20140020470 A KR20140020470 A KR 20140020470A KR 1020120086900 A KR1020120086900 A KR 1020120086900A KR 20120086900 A KR20120086900 A KR 20120086900A KR 20140020470 A KR20140020470 A KR 20140020470A
- Authority
- KR
- South Korea
- Prior art keywords
- gaba
- lactobacillus helveticus
- extract
- starter
- rmk85
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
본 발명은 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85를 이용하여 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법에 관한 것이다.The present invention relates to Lactobacillus < RTI ID = 0.0 > The present invention relates to a method for producing a fermented herbal medicine extract in which gamma-aminobutyric acid (GABA) is promoted using helveticus RMK85.
감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)은 억제성 신경전달물질로서 혈압상승을 억제하고 시력증진에 효과가 있으며 불안감, 초조감 등을 진정시키는 작용을 하는 것으로 알려진 물질이다. 동물의 경우 뇌, 심장, 폐, 신장 등에 분포되어 있으며, 식물의 경우 발아현미, 녹차 등에서 주로 발견되고 있다. 스트레스에 시달리는 현대인이나 수험생, 알코올 과다 섭취자의 경우 뇌와 혈중 GABA 농도가 낮은 것으로 보고되어 있으며, 체내 GABA 농도의 극심한 부족은 발작, 경련, 간질 증세를 일으키는 것으로 알려져 있다.Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter, which is known to inhibit blood pressure buildup, improve visual acuity, and calm anxiety and nervousness. In animals, it is distributed in the brain, heart, lung, kidney, etc. In the case of plants, it is mainly found in germinated brown rice and green tea. Hypnotists, examinees, and alcohol-consuming sufferers suffering from stress are reported to have low levels of GABA in the brain and blood, and a severe shortage of GABA in the body is known to cause seizures, convulsions, and epilepsy.
이러한 GABA의 기능성이 알려지면서 의약품으로서 뿐만 아니라 기능성 식품 소재로서 관심이 높아지고 있다. 현재 GABA는 현미, 녹차, 맥아, 배추 등에 자연적으로 약간 함유되어 있으나, 그 함량이 낮아 자연 식품으로 섭취하는 양으로는 생리활성을 기대하기 어렵다. 이러한 식물들의 GABA 함유량을 높이기 위해서 차잎과 보리맥아 제조시 발아된 보리의 혐기적 처리와 현미 발아시 글루탐산(glutamic acid) 첨가를 통하여 식물체 내 GABA 함량을 증가시켰다(Chang et al., 1992; Jeon et al., 2004; Park et al., 2001; Yokoyama et al., 2002). 그러나 식물을 원재료로 한 GABA의 생산에는 한계가 있으므로 GABA 대량생산을 위해 미생물을 이용한 많은 연구가 수행되고 있다. 이중 젖산균은 인간이 이용할 수 있는 가장 유익한 미생물의 한 종류로서 예로부터 발효 유제품을 중심으로 장류, 김치, 젓갈, 소시지, 의약품 등에 걸쳐 인류생활에 폭넓게 활용되어 내려오고 있다. 하지만, GABA를 생산하는 균주의 분리 및 개량에 대한 연구는 다양한 측면에서 이루어진데 반해 GABA의 함량을 높인 식품이나 기능성 음료에 관한 연구는 아직 미비한 실정이다.
As the function of GABA is known, interest as functional food materials as well as pharmaceuticals is increasing. Currently, GABA is slightly contained in brown rice, green tea, malt, and cabbage, but its content is low and it is difficult to expect physiological activity by the amount of natural food. In order to increase the GABA content of these plants, GABA content in the plant was increased by anaerobic treatment of barley germinated in the preparation of tea leaves and barley malt, and glutamic acid addition during brown germination (Chang et al., 1992; Park et al., 2001; Yokoyama et al., 2002). However, since there is a limit to the production of GABA using plant-based materials, many studies using microorganisms for mass production of GABA have been conducted. Among them, lactic acid bacteria are one of the most beneficial microorganisms that can be used by human beings, and they have been used widely in fermented dairy products, such as soy sauce, kimchi, salted fish, sausages and medicines. However, studies on the isolation and improvement of strains producing GABA have been made in various aspects, but studies on foods or functional beverages having increased contents of GABA have not been studied yet.
한편, 한국등록특허 제0404921호에서는 건망증 개선 효능이 있는 총명차의 제조방법을 개시하고 있으나, 이는 원지, 감초 등의 한방 생약재가 혼합된 총명차로서 젖산균을 이용한 발효나 GABA에 대한 언급이 없다. 따라서, 본 발명자들은 총명탕의 주요 약재로 사용되는 석창포, 원지 및 복령 추출물의 젖산 발효를 통해 GABA 함량을 증진시킨 발효 생약 추출물을 제조하여 본 발명을 완성하였다.On the other hand, Korean Patent No. 0404921 discloses a preparation method of tea ginseng which has ameliorating effect for forgetfulness, but it is not mentioned about fermentation using lactic acid bacteria or GABA as a total ginseng mixed with oriental herb medicine such as Japanese papaya and licorice. Accordingly, the inventors of the present invention have completed the present invention by preparing fermented herbal medicine extracts in which the content of GABA was enhanced through lactic acid fermentation of extracts of Seokchangpo, native and ginseng, which are used as main medicines of Sogwangju.
본 발명의 목적은 젖산균인 락토바실러스 헬베티커스(Lactobacillus helveticus) 스타터를 이용하여 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법을 제공하는 데에 있다.It is an object of the present invention to provide a method for producing a fermented herbal medicine extract in which gamma-aminobutyric acid (GABA) is promoted using lactobacillus Lactobacillus helveticus starter.
본 발명의 다른 목적은 상기의 방법에 의해 제조된 GABA가 증진된 발효 생약 추출물을 제공하는 데에 있다.Another object of the present invention is to provide a GABA-enhanced fermented herbal medicine extract prepared by the above method.
상기 목적을 달성하기 위하여, 본 발명은 배지에서 락토바실러스 헬베티커스를 배양하여 스타터(starter)를 준비하는 단계; 상기 락토바실러스 헬베티커스 스타터를 0.1 내지 10 중량% 글루코즈(glucose) 및 0.1 내지 5 중량% 효모추출물(yeast extract)이 포함된 생약 추출물에 접종하는 단계; 및 상기 접종된 생약추출물을 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법을 제공한다. 상세하게는, 상기 배지에는 0.1 내지 1 중량% 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 더 첨가하는 것을 특징으로 한다.In order to accomplish the above object, the present invention provides a method for culturing Lactobacillus helveticus, comprising culturing Lactobacillus helveticus in a culture medium to prepare a starter; Inoculating the Lactobacillus helveticus starter with a crude drug extract containing 0.1 to 10% by weight glucose and 0.1 to 5% by weight yeast extract; And a step of fermenting the inoculated herbal medicine extract, wherein the gamma-aminobutyric acid (GABA) is promoted. Specifically, the medium is further supplemented with 0.1 to 1% by weight of monosodium glutamate (MSG).
본 발명에 있어서, "스타터(starter)"란 발효물을 제조하는 경우에 사용하는 미생물 배양액을 말한다. 따라서 스타터 미생물의 종류는 그 제품의 특성을 결정하게 되며 제품의 품질에 중요한 영향을 미친다. 미생물 중에서 스타터로 사용되고 있는 것은 박테리아, 곰팡이, 효모 등을 들 수 있으며, 이것을 단독 혹은 혼합하여 사용할 수 있다.In the present invention, the term "starter" refers to a culture medium of microorganisms used for producing a fermented product. Therefore, the types of starter microorganisms determine the characteristics of the product and have an important influence on the quality of the product. Bacteria, fungi, yeast, etc., which are used as starters in microorganisms, can be used alone or in combination.
상기 배지로는 락토바실러스(Lactobacillus) MRS 배지가 바람직하나, 상기 균주의 배양에 적합한 배지라면 특별히 이에 한정되는 것은 아니다. The medium is preferably a Lactobacillus MRS medium, but is not particularly limited as long as it is a medium suitable for culturing the strain.
상기 MSG의 첨가량이 0.1 중량% 이하인 경우 GABA 생성에 필요한 전구물질이 부족하게 되는 문제가 발생할 수 있고, 1.0 중량%을 초과하는 경우 GABA로 전환되지 않은 MSG가 남아 있게 되는 문제가 발생할 수 있다.
If the amount of MSG added is less than 0.1 wt%, the precursor necessary for GABA production may be insufficient. If the amount of MSG is more than 1.0 wt%, MSG not converted to GABA may remain.
또한 본 발명에 있어서, 상기 생약 추출물은 원지, 백복령 및 석창포를 1:1:1의 중량비로 열수 추출한 것을 특징으로 하고, 상기 락토바실러스 헬베티커스는 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85(KACC91721P)인 것을 특징으로 한다. In the present invention, the herbal extract of the base paper, and baekbokryeong seokchangpo 1: 1: wherein the hot-water extract at a weight ratio of 1, wherein said Lactobacillus helveticus is Lactobacillus helveticus coarse coarse (Lactobacillus helveticus RMK85 (KACC91721P).
본 발명에 있어서, "총명탕"은 백복신, 원지, 감초 및 석창포의 4가지 천연 생약재로 구성된 한약조성물로서 동의보감에는 '치다망구복능일송천언'(治多忘久服能日誦千言)라 하여 '잘 잊어버리는 것을 치료하고 오랫동안 먹으면 능히 하루에 천가지 말을 외우게 된다.'라고 기록되어 있다(출처:네이버 백과사전). 본 발명에서는 원지 300g, 백복령 300g, 석창포 300g을 물 13,000mL와 함께 약탕기에 넣고 120℃에서 총 3시간을 가열하여 생약추출물 또는 총명탕을 제조하였다.
In the present invention, "Sungmyunggang" is a herb medicine composition composed of four natural herbal medicines, such as white ginseng, lavender, liquorice, and licorice root, which is called " If you forget to forget and eat for a long time, you will be able to memorize a thousand words a day. "(Source: Naver Encyclopedia). In the present invention, 300 g of raw paper, 300 g of Baekbokryeong, and 300 g of Seokchangpo were added to a hot water machine together with 13,000 mL of water and heated at 120 캜 for a total of 3 hours to prepare a herbal extract or a common mint.
또한, 상기 접종하는 단계는 상기 락토바실러스 헬베티커스 스타터를 1 내지 10%(v/v) 접종하는 것을 특징으로 하고, 상기 발효시키는 단계는 25 내지 42℃에서 12 내지 72시간 동안 발효하는 것을 특징으로 한다.
The inoculating step is characterized in that 1 to 10% (v / v) of the Lactobacillus helveticus starter is inoculated, and the step of fermenting comprises fermenting at 25 to 42 ° C for 12 to 72 hours .
상기 락토바실러스 헬베티커스 스타터의 접종량이 1 %(v/v) 이하인 경우 저농도의 균주로 인해 감마-아미노부틸산을 고함량으로 생산할 수 없고, 10 %(v/v)을 초과하는 경우 너무 빨리 발효되는 문제가 발생할 수 있다.
When the inoculation amount of the Lactobacillus helveticus starter is less than 1% (v / v), gamma-aminobutyric acid can not be produced in a high content due to low concentration of the strain, and if it exceeds 10% (v / v) The fermentation may occur.
또한, 본 발명은 상기의 방법에 의해 제조된 GABA가 증진된 발효 생약 추출물을 제공한다.In addition, the present invention provides a fermented herbal medicine extract having enhanced GABA produced by the above method.
본 발명자들은 생약 추출물(석창포, 원지 및 복령 추출물)의 젖산 발효를 통해 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA) 함량을 증진시킨 발효 생약 추출물을 제조하였고, 이를 활용하여 고함량의 GABA가 포함된 기능성 음료 및 식품 개발의 가능성을 높일 수 있다.The inventors of the present invention prepared fermented herbal medicine extracts by enhancing the content of gamma-aminobutyric acid (GABA) through lactic acid fermentation of herbal medicine extracts (Seokchangpo, native and extracts) and found that a high content of GABA It is possible to increase the possibility of developing functional beverages and foods containing them.
도 1은 MSG가 첨가된 경우(0.5%)와 첨가되지 않은 경우, 균주 종류에 따른 GABA 생성을 확인한 TLC 결과이다.
도 2는 MRS 배지와 생약 추출물의 비율에 따른 GABA 생산능을 확인한 TLC 결과이다.
도 3은 효모추출물(yeast extract)의 농도에 따른 GABA 생산능을 확인한 TLC 결과이다.
도 4는 스타터(starter) 접종 조건에 따른 GABA 생산능을 확인한 TLC 결과이다.
도 5은 GABA 함량을 증진시킨 발효 생약 추출물을 제조하기 위한 발효공정도를 나타낸다.FIG. 1 shows the results of TLC in which MSG was added (0.5%) and GABA production was confirmed by strain type when not added.
FIG. 2 shows TLC results showing the ability of GABA production according to the ratio of MRS medium and herbal medicine extract.
FIG. 3 shows the results of TLC showing the ability of GABA production according to the concentration of yeast extract.
FIG. 4 shows TLC results confirming GABA production ability according to starter inoculation conditions.
FIG. 5 shows a fermentation process diagram for preparing a fermented herbal medicine extract having enhanced GABA content.
이하, 하기 실시예를 통해 본 발명을 보다 상세하게 설명한다. 다만, 이러한 실시예에 의해 본 발명이 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the present invention is not limited by these examples.
< <
실시예Example
1 > 균주 종류에 따른 1> Depending on the strain type
GABAGABA
생성능Generation
확인 Confirm
1. 균주 배양 방법1. Culture method of strain
원유에서 분리한 5가지 균주인 Enterococcus faecalis K48, Lactobacillus helveticus RMK85, Enterococcus faecium K36, Lactobacillus acidophilus RMK 567, Streptococcus macedonicus K49는 Lactobacilli MRS agar 배지(Difco co., Ltd.)에서 단일 콜로니(colony)가 나타나게 배양한 후, MRS 배지(broth)에 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 0.5% 첨가한 구와 첨가하지 않은 구로 나누어 접종한 뒤 30℃에서 24시간 동안 배양하였다.
Five strains isolated from crude oil, Enterococcus faecalis K48, Lactobacillus helveticus RMK85, Enterococcus faecium K36, Lactobacillus acidophilus RMK 567, Streptococcus macedonicus K49 The cells were cultured so that a single colony appeared on Lactobacilli MRS agar medium (Difco co., Ltd.), then cultured in MRS medium broth supplemented with 0.5% monosodium glutamate (MSG) And cultured at 30 ° C for 24 hours.
2. TLC 측정방법2. TLC measurement method
샘플에 함유된 MSG 및 생성된 GABA 함량은 TLC(Silica gel 60 F254, Merck)로 확인하였다. 배양액 1mL을 speed vaccum을 이용하여 4배 농축하여 TLC plate에 2uL 점적하였다. 분석 시 전개용매로는 아세트산(acetic acid): n-부틸 알콜(n-butyl alcohol): 증류수(distilled water) (2:6:2, v/v/v)의 비율로 조제하여 4시간 이상 포화시킨 용매를 사용하였고, 발색 시약으로 0.2% 닌하이드린 용액(ninhydrin solution)을 분무하여 95℃에서 5분간 발색시켜 스팟(spot)을 확인하였다. 그 결과 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85가 GABA 생산능이 가장 우수하였으며, MSG 첨가에 의해 GABA 생산량이 높아지는 것을 확인하였다(도 1).
The MSG contained in the sample and the produced GABA content were confirmed by TLC (
< <
실시예Example
2 > 2>
MRSMRS
배지 농도에 따른 Depending on the concentration of the medium
GABAGABA
생성능Generation
확인 Confirm
MRS 배지 농도에 따른 GABA 생성능을 확인하기 위해서, 원지 300g, 백복령 300g, 석창포 300g을 물 13,000mL와 함께 약탕기에 넣고 120℃에서 총 3시간을 가열하여 미리 제조한 생약추출물에 MRS 배지를 0~100%(v/v)의 농도로 첨가하여 실험하였다. 균주로는 GABA 생성능이 우수한 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주를 사용하였는데, 이는 MRS 배지에 30℃에서 24시간 동안 배양한 스타터(starter)를 5%(v/v) 첨가하여 24시간 동안 발효하였다. To confirm the GABA production ability according to the MRS medium concentration, 300 g of raw cotton, 300 g of Baekbok-ryeong and 300 g of Seokchangpo were poured into a hot water pot with 13,000 mL of water and heated for 3 hours at 120 ° C. for 3 hours to prepare MRS medium % (v / v). As a strain, Lactobacillus helveticus RMK85 strain, which has excellent GABA production ability, was used. This strain was added to 5% (v / v) starter cultured at 30 ° C for 24 hours in MRS medium, Lt; / RTI >
각각 pH와 총산도(Total acidity)를 측정하였는데, pH는 각 샘플 10mL을 원심 분리한 상층액을 pH meter (Digital pH meter 420A+, Thermo Orion. Beverly, MA., USA)를 이용하여 측정하였고, 적정 산도는 상층액 10mL를 취하여 pH가 8.3에 도달할 때까지 0.1N-NaOH로 적정에 사용된 소비량을 젖산(lactic acid) 함량(%)으로 환산하여 계산하였다.
The pH and total acidity of each sample were measured by centrifuging each sample in 10 mL of the supernatant using a pH meter (Digital pH meter 420A +, Thermo Orion Beverly, MA, USA) The acidity was calculated by taking 10 mL of the supernatant and converting the amount used for titration with 0.1 N-NaOH to the lactic acid content (%) until the pH reached 8.3.
그 결과, MRS 배지의 농도가 높아질수록 비교적 좋은 GABA 생산을 하는 것을 확인하였으나(도 2), MRS 배지는 식용으로 적합하지 않은 소재로 판단하여 MRS 배지의 영양성분 중 탄소원과 질소원의 영향을 검토하여 영양원만을 생약 추출물에 첨가하기로 하였다. pH가 감소하고 총산도가 증가하는 것은 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주가 생장하고 있다는 것을 의미하여 균주의 생장이 활발할 때 GABA 생산도 증가한다고 판단된다(표 2). 즉, 균주의 생장이 활발할 경우 균주가 가지고 있는 글루탐산탈탄산효소(Glutamate decarboxylase)의 활성이 활발해져 기질인 모노소디움글루타메이트(Monosodium Glutamate, MSG)를 분해하여 GABA 생성이 높아지게 된다.
As a result, it was confirmed that the higher the concentration of MRS medium, the better the production of GABA (Fig. 2). However, the MRS medium was judged as not suitable for food, and the influence of carbon source and nitrogen source Only the nutrient source was added to the herbal medicine extract. The decrease in pH and the increase in total acidity are due to Lactobacillus < RTI ID = 0.0 > The means and the helveticus) strains RMK85 growth is determined to increase GABA production when the growth of the strain hwalbalhal (Table 2). That is, when the strain is active, the activity of the glutamate decarboxylase (Glutamate decarboxylase) of the strain becomes active, thereby decomposing the substrate, monosodium glutamate (MSG), resulting in increased GABA production.
< <
실시예Example
3 > 3>
YeastYeast
extractextract
농도에 따른 Depending on concentration
GABAGABA
생성능Generation
확인 Confirm
glucose 2%에 Yeast extract를 1~2.5%까지 농도를 달리하여 젖산발효를 하여 TLC로 GABA 생산능을 측정하였을 때, glucose 2%에 Yeast extract 2%와 2.5%를 첨가한 조건에서 GABA 생산능이 가장 뛰어난 것을 확인하였다(도 3). 한편 pH 및 총산도의 측정 결과, 균주가 생장에도 문제가 없음을 확인하였다(표 3). When 2% of yeast extract was added to 2% of glucose and lactic acid fermentation was performed at 1 ~ 2.5% concentration, GABA production ability was measured by TLC. When 2% of glucose and 2% of yeast extract were added, (Fig. 3). As a result of measurement of pH and total acidity, it was confirmed that there was no problem in growth of the strain (Table 3).
따라서 기본 배지 조성은 생약 추출물을 기본배지로 하여 glucose 2% 와 Yeast extract 2.5%를 사용하였다.
Therefore, 2% of glucose and 2.5% of yeast extract were used as the basic medium for herb extract.
< <
실시예Example
4 > 스타터( 4> starter
starterstarter
) 접종 조건에 따른 ) Depending on the vaccination condition
GABAGABA
생산능Production capacity
확인 Confirm
생약 추출물에 glucose 2%와 yeast extract 2.5%를 첨가한 조건에 스타터(starter) 접종 방식을 달리하여 GABA 생산능을 확인하였다. MRS 배지에 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주를 배양한 스타터(starter)를 5% 접종, MRS 배지에 0.5% MSG를 첨가하여 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주를 배양한 스타터(starter)를 5% 접종 및 스타터(starter)의 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균체를 모아서 농축하여 접종 조건에서 실험을 수행하였다(표 4). 그 결과, MSG를 0.5% 첨가한 스타터(starter)를 이용한 생약 추출물이 GABA 함량이 가장 많은 것을 확인하였다(도 4).
GABA production ability was determined by adding starter inoculation method to 2% of glucose and 2.5% of yeast extract. MRS medium supplemented with Lactobacillus < RTI ID = 0.0 > helveticus RMK85 strain was inoculated with 5% starter and 0.5% MSG was added to MRS medium to obtain Lactobacillus helveticus ) Starter cultured in RMK85 strain was inoculated into a 5% inoculum and a starter Lactobacillus ( Lactobacillus) helveticus RMK85 cells were collected and enriched and tested under inoculation conditions (Table 4). As a result, it was confirmed that the herbal medicine extract using starter with 0.5% MSG had the highest GABA content (FIG. 4).
(Total acidity)Total acidity (%)
(Total acidity)
Glucose 2%+
Y.E. 2.5%Herbal extract +
YE 2.5
Starter 5%MSG 0.5%
한편, 상기 각 조건별로 발효된 생약추출물 발효물에 함유된 GABA 함량을 HPLC로 분석한 결과, 발효하지 않은 생약추출물에 비해 발효 후 약 3배 이상 GABA가 증가 되는 것을 확인하였다(표 5).
The GABA content in the fermented herbal extract fermented by each of the above conditions was analyzed by HPLC. As a result, it was confirmed that GABA was increased about 3 times or more after fermentation compared to the fermented herbal medicine extract (Table 5).
+Y.E. 2%+Starter 5%Herbal extract +
+
+Y.E. 2.5%+
Starter 5% (MSG 0.5%)Herbal extract +
+ YE 2.5% +
Claims (7)
상기 락토바실러스 헬베티커스 스타터를 0.1 내지 10 중량% 글루코즈(glucose) 및 0.1 내지 5 중량% 효모추출물(yeast extract)이 포함된 생약 추출물에 접종하는 단계; 및
상기 접종된 생약 추출물을 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법.Preparing a starter by culturing Lactobacillus helveticus in the medium;
Inoculating the Lactobacillus helveticus starter with a herbal extract comprising 0.1 to 10 wt% glucose and 0.1 to 5 wt% yeast extract; And
A method for producing a fermented herbal medicine extract, wherein gamma-aminobutyric acid (GABA) is enhanced, comprising fermenting the herbal herb extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120086900A KR101407231B1 (en) | 2012-08-08 | 2012-08-08 | Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120086900A KR101407231B1 (en) | 2012-08-08 | 2012-08-08 | Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140020470A true KR20140020470A (en) | 2014-02-19 |
KR101407231B1 KR101407231B1 (en) | 2014-06-13 |
Family
ID=50267440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120086900A KR101407231B1 (en) | 2012-08-08 | 2012-08-08 | Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101407231B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190105956A (en) * | 2018-03-07 | 2019-09-18 | 사단법인 제주석창포쉼사업단 | A Method for Preparing Fermented Acorus gramineus with a Reduced Content of Beta-Asarone |
CN113699067A (en) * | 2021-08-24 | 2021-11-26 | 杭州娃哈哈科技有限公司 | Lactobacillus helveticus, high-yield GABA (gamma-aminobutyric acid) direct vat set starter and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102254560B1 (en) | 2020-12-08 | 2021-05-21 | (주)안온바이오 | Extract of Liriope platyphylla with increased gaba content and anti-inflammatory composition comprising the same |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100867612B1 (en) * | 2006-04-03 | 2008-11-10 | 황귀서 | Composition comprising sungnoiwon for improving brain function and memory dysfunction |
KR20110010433A (en) * | 2009-07-24 | 2011-02-01 | 강원대학교산학협력단 | The preparing method for soybean milk with natural gaba using serial fermentation of plant originated lactic acid bacteria with gaba-producing ability and protease-producing ability |
-
2012
- 2012-08-08 KR KR1020120086900A patent/KR101407231B1/en active IP Right Grant
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20190105956A (en) * | 2018-03-07 | 2019-09-18 | 사단법인 제주석창포쉼사업단 | A Method for Preparing Fermented Acorus gramineus with a Reduced Content of Beta-Asarone |
CN113699067A (en) * | 2021-08-24 | 2021-11-26 | 杭州娃哈哈科技有限公司 | Lactobacillus helveticus, high-yield GABA (gamma-aminobutyric acid) direct vat set starter and application thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101407231B1 (en) | 2014-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101402031B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154 | |
KR100919213B1 (en) | Function-related fermentation raw materials using the composition which mixed chlorella in Rubus coreanus and Method to produce thereof | |
CN108260808B (en) | Noni enzyme and preparation method thereof | |
JP4815493B2 (en) | Medium composition containing fermented gochujang, brewed soy sauce stock or acid-decomposed soy sauce stock, and method for producing γ-aminobutyric acid | |
WO2017210815A1 (en) | Microbial strain and application thereof in production of pu'er tea | |
CN107937311B (en) | Streptococcus thermophilus for high yield of gamma-aminobutyric acid, preservation and culture method and method for preparing fermented milk by using streptococcus thermophilus | |
WO2020140319A1 (en) | Lactobacillus paracasei and use thereof | |
KR101091833B1 (en) | Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria | |
KR101407231B1 (en) | Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 | |
KR101799400B1 (en) | Medium composition comprising amino acids for sparassis latifolia mycelium and the production method of the sparassis latifolia mycelium with improved gamma-amino butyrate using the same | |
CN109355212A (en) | One Aspergillus oryzae ZA132 and its application | |
KR101501827B1 (en) | Method for manufacturing base of watery radish kimchi using GABA producing Lactobacillus and Opuntia humifusa | |
KR20220094359A (en) | Method for manufacturing Morinda citrifolia fortified with higher GABA content using Lactic acid bacteria having GABA-producing activity | |
KR102007569B1 (en) | Fermentation product of seomae mugwort with high palatability and functionality, and method for preparing the same | |
KR101884999B1 (en) | Manufacturing method of Dendropanax morbifera fermentation product having antioxidant function using Lactobacillus sp. | |
KR20130075889A (en) | Soybean composition containing conjugated linoleic acid and a fabrication process thereof and food containing it | |
CN112899117A (en) | Method for co-fermenting high gamma-aminobutyric acid red date and pearl barley vinegar by combining monascus with lactobacillus and spore bacteria | |
KR101842196B1 (en) | Functional makgeolli and method for preparation thereof | |
CN112515008A (en) | Method for improving quality of black tea through aspergillus niger fungus | |
KR100963133B1 (en) | Function-related fermentation food using the composition which mixed chlorella in Rubus coreanus and method to produce thereof | |
CN110250464A (en) | A kind of preparation method of the Selenium-enriched fermentation phoenix head salty base of ginger | |
Lee et al. | Chemistry of the Korean Traditional Alcoholic Beverage Makgeolli | |
JP7329221B2 (en) | Saccharopolyspora composition and its use in food | |
CN117337969B (en) | Medicinal and edible ferment, and preparation method and application thereof | |
KR101670321B1 (en) | Manufacturing method of garlic extract of high quantity Cycloalliin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170607 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180711 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20190710 Year of fee payment: 6 |